Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood.
J Immunother Cancer
; 9(5)2021 05.
Article
in En
| MEDLINE
| ID: mdl-33963011
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Monocytes
/
Calgranulin B
/
Programmed Cell Death 1 Receptor
/
Nivolumab
/
Immune Checkpoint Inhibitors
/
Melanoma
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Document type:
Article